Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 10101 - 10125 of 10948 in total

N-acetyl-alpha-D-glucosamine

The N-acetyl derivative of glucosamine.
Experimental
Matched Description: … The N-acetyl derivative of glucosamine. …

Desmethylsertraline

Desmethylsertraline is a metabolite of sertraline.
Experimental
Matched Description: … Desmethylsertraline is a metabolite of sertraline. …

Arachidonyltrifluoromethane

Specific inhibitor of phospholipase A2.
Investigational
Matched Description: … Specific inhibitor of phospholipase A2.[A252972] …

Ferrous aspartate

The use of ferrous acetate over ferrous sulfate is currently undergoing an investigation by a clinical trial . It is also used for dying of fabric or leather and as a wood preservative.
Experimental
Matched Description: … It is also used for dying of fabric or leather and as a wood preservative. ... The use of ferrous acetate over ferrous sulfate is currently undergoing an investigation by a clinical …

Octopamine

Octopamine is structurally similar to norepinephrine. It has been used as a nootropic, and therefore it and all of its enantiomer are prohibited by the World Anti-doping Agency (WADA) as of 2014.
Experimental
Matched Description: … Anti-doping Agency (WADA) as of 2014. ... It has been used as a nootropic, and therefore it and all of its enantiomer are prohibited by the World …

ADU-S100

ADU-S100 (MIW815) is a synthetic cyclic dinucleotide (CDN) agonist (activator) of Stimulator of Interferon Genes (STING), a receptor crucial to activate the innate (endogenous) immune system. ADU-S100 (MIW815) activates all known human and mouse STINGs, and effectively induces the expression of cytokines and chemokines, leading to a robust and durable...
Investigational
Matched Description: … ADU-S100 (MIW815) is a synthetic cyclic dinucleotide (CDN) agonist (activator) of Stimulator of Interferon ... ADU-S100 (MIW815) activates all known human and mouse STINGs, and effectively induces the expression of …

PZM21

PZM21 is a novel μ-opioid receptor (MOPr) ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ-opioid ligands such as morphine.
Experimental
Matched Description: … receptor (MOPr) ligand that has been reported to induce minimal arrestin recruitment and be devoid of ... the respiratory depressant effects characteristic of classical μ-opioid ligands such as morphine. …

M-2698

M-2698 is under investigation in clinical trial NCT01971515 (First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies).
Investigational
Matched Description: … M-2698 is under investigation in clinical trial NCT01971515 (First-in-Human Dose Escalation Trial in …

Exicorilant

Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
Investigational
Matched Description: … Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination ... With Enzalutamide in Patients With Mcrpc). …

Fluorocyclopentenylcytosine

Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
Investigational
Matched Description: … Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination ... With Abraxane® in Subjects With Metastatic Pancreatic Cancer). …

Cabiralizumab

Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).
Investigational
Matched Description: … in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma). ... Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab …

Ningetinib

Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
Investigational
Matched Iupac: … N-(3-fluoro-4-{[7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl]oxy}phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3 …
Matched Description: … in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative). ... Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib …

Ispinesib

Investigational
Matched Iupac: … N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide …

EA-2353

EA-2353 is a small molecule inhibitor of kinase mediators of the Wnt pathway.
Investigational
Matched Description: … EA-2353 is a small molecule inhibitor of kinase mediators of the Wnt pathway. …

Palucorcel

Palucorcel is an investigational stem cell therapy consisting of human umbilical tissue-derived cells. Developed by Janssen Biotech, it is being investigated for the treatment of various conditions such as amyotrophic lateral sclerosis (ALS) and macular degeneration.
Investigational
Matched Description: … Palucorcel is an investigational stem cell therapy consisting of human umbilical tissue-derived cells ... Developed by Janssen Biotech, it is being investigated for the treatment of various conditions such as …

Thiostrepton

Thiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii. Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide class.
Vet approved
Matched Description: … Thiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes ... Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide …

2-phospho-D-glyceric acid

A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.
Experimental
Matched Description: … A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration. …

Terpinen-4-ol

Terpinen-4-ol is under investigation in clinical trial NCT01647217 (Demodex Blepharitis Treatment Study).
Investigational
Matched Description: … Terpinen-4-ol is under investigation in clinical trial NCT01647217 (Demodex Blepharitis Treatment Study …

Farampator

Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).
Investigational
Matched Description: … Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression) …

Vidofludimus

Vidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing Cholangitis).
Investigational
Matched Description: … Vidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing …

BVX-001

BVX001 is a a novel, first-in-class CD33/CD7-directed antibody-drug conjugate.
Investigational
Matched Description: … BVX001 is a a novel, first-in-class CD33/CD7-directed antibody-drug conjugate. …

Furaprevir

Furaprevir is under investigation in clinical trial NCT01523990 (A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients).
Investigational
Matched Iupac: … ,3,5,10,12-hexaen-6-yl}oxy)-3,16-diazatricyclo[14.3.0.0^{4,6}]nonadec-7-en-14-yl]carbamate ... }-2,15-dioxo-18-({4-[4-(propan-2-yloxy)phenyl]-8-oxa-3,5-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7) …
Matched Description: … , and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients). ... Furaprevir is under investigation in clinical trial NCT01523990 (A Study to Evaluate the Safety, Tolerability …

Bintrafusp alfa

Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)).
Investigational
Matched Description: … Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced …

Anti-GD2 monoclonal antibody 3F8

Anti-GD2 monoclonal antibody 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).
Investigational
Matched Description: … in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment). ... Anti-GD2 monoclonal antibody 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy …

PAT-1251

PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocytosis Myelofibrosis).
Investigational
Matched Description: … PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary …
Displaying drugs 10101 - 10125 of 10948 in total